Prognostic implication of estrogen receptor content in breast cancer
- 1 October 1985
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 5 (3), 293-300
- https://doi.org/10.1007/bf01806024
Abstract
The cytosolic estrogen receptor (ER) content of the primary tumor was determined by isoelectric focusing in 170 consecutive women with unilateral breast cancer diagnosed in 1977 through 1980. No adjuvant treatment over and above surgery and radiotherapy was given. The overall corrected survival was not significantly (p>0.05) higher in ER-rich (<0.1 nmol/g DNA) than in ER-poor tumors, but the median period from recurrence to death was longer in the former (16 months) than in the latter (10 months) group. The difference in disease-free survival (DFS) in favour of the ER-rich tumors achieved its maximum — about 15% — after two years (p<0.01). At prolonged follow-up, however, the curves converged and there was no significant difference when the whole six year period of observation was taken into account. In patients without axillary metastases the same pattern emerged, with earlier recurrences in ER-poor tumors and a difference in DFS between the two ER groups at two years (p<0.01) which was diminished after five years (p<0.05). The ER content provided no significant prognostic information in patients with axillary node metastases or locally advanced disease. We conclude from the present and other available data that the ER content in breast cancer would seem to be an indicator of growth rate rather than of metastatic potential and accordingly a predictor of the pattern of recurrence and length of disease-free survival rather than of long-term survival.This publication has 26 references indexed in Scilit:
- Markers and prognostic factors in breast cancer disease; Workshop reportEuropean Journal of Cancer and Clinical Oncology, 1983
- Biology of breast cancer: Receptors; Workshop reportEuropean Journal of Cancer and Clinical Oncology, 1983
- Prognostic value of estrogen and progesterone receptors in primary breast cancerBreast Cancer Research and Treatment, 1983
- Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsBreast Cancer Research and Treatment, 1982
- Steroid receptors in early breast cancer: Value in prognosisJournal of Steroid Biochemistry, 1981
- Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: A study of 583 patientsInternational Journal of Cancer, 1981
- Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinomaEuropean Journal of Cancer (1965), 1980
- RELATIONSHIP OF ŒSTROGEN-RECEPTOR STATUS TO SURVIVAL IN BREAST CANCERThe Lancet, 1979
- Cytosol estradiol receptor in human mammary carcinoma: An assay based on isoelectric focusing in polyacrylamide gelAnalytical Biochemistry, 1978
- [105] Determination of DNA concentration with diphenylamineMethods in Enzymology, 1968